These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32918547)

  • 1. Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.
    Spinicci M; Zammarchi L; Gramiccia M; Di Muccio T; Bartolozzi D; Corsi P; Trotta M; Bartoloni A
    J Travel Med; 2021 Aug; 28(6):. PubMed ID: 32918547
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico.
    Vargas-Gonzalez A; Canto-Lara SB; Damian-Centeno AG; Andrade-Narvaez FJ
    Am J Trop Med Hyg; 1999 Dec; 61(6):960-3. PubMed ID: 10674678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of pathogenic bacteria in skin lesions of patients with chiclero's ulcer. Reluctant response to antimonial treatment.
    Isaac-Márquez AP; Lezama-Dávila CM
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1093-5. PubMed ID: 15049096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous leishmaniasis "chiclero's ulcer" in subtropical Ecuador.
    Calvopiña M; Martinez L; Hashiguchi Y
    Am J Trop Med Hyg; 2013 Aug; 89(2):195-196. PubMed ID: 23926136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional injections of meglumine antimoniate to treat complex facial leishmania infantum acquired in Spain: a case report.
    Mostmans Y; Van Gysel J; Vanden Nest H; Mervillie K; Richert B; Clevenbergh P
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e548-e550. PubMed ID: 35181939
    [No Abstract]   [Full Text] [Related]  

  • 6. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
    Yeşilova Y; Turan E; Sürücü HA; Aksoy M; Özbilgin A
    Turkiye Parazitol Derg; 2015 Mar; 39(1):63-5. PubMed ID: 25917587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic Alterations Related to Intralesional Glucantime® Treatments: A Potentially Severe Adverse Event.
    García Bracamonte B; Burillo Martínez S; Morales Raya C; Ortiz Romero P
    Actas Dermosifiliogr; 2022; 113(7):742-744. PubMed ID: 35331726
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis.
    Neves LO; Talhari AC; Gadelha EP; Silva Júnior RM; Guerra JA; Ferreira LC; Talhari S
    An Bras Dermatol; 2011; 86(6):1092-101. PubMed ID: 22281895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of imported New World cutaneous leishmaniasis in Germany.
    Harms G; Scherbaum H; Reiter-Owona I; Stich A; Richter J
    Int J Dermatol; 2011 Nov; 50(11):1336-1342. PubMed ID: 22004484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Of Efficacy Of Miltefosine Versus Meglumine Antimonate In The Treatment Of Cutaneous Leishmaniasis.
    Mohammad N; Sagheer F; Paracha MM; Khan AQ; Naseem S; Wasim M
    J Ayub Med Coll Abbottabad; 2022; 34(4):849-853. PubMed ID: 36566412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personal experience with diagnostic and therapeutic aspects of human Leishmania (Viannia) braziliensis in Três Braços.
    Marsden PD
    Mem Inst Oswaldo Cruz; 1994; 89(3):485-7. PubMed ID: 7476237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family cluster of cutaneous Leishmania major infection unresponsive to intralesional meglumine antimonial: Case reports.
    Ziaee M; Ghatee MA; Taylor WR; Karamian M
    Indian J Med Microbiol; 2022; 40(3):451-454. PubMed ID: 35680474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
    Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
    AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.
    Khamesipour A; Mohammadi A; Jaafari M; Eskandari S; Tasbihi M; Javadi A; Afshari F; Mortazavi H; Firooz A
    East Mediterr Health J; 2022 Sep; 28(9):658-663. PubMed ID: 36205204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A
    Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of
    Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
    Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial.
    Lago J; Fraga D; Guimarães LH; Lago T; Silva YJ; Lago E; Werneck GL; Bacellar O; Carvalho EM
    PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011064. PubMed ID: 36791065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.
    Nonata R; Sampaio R; Marsden PD
    Trans R Soc Trop Med Hyg; 1997; 91(1):77. PubMed ID: 9093636
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B].
    Sampaio RN; Marsden PD
    Rev Soc Bras Med Trop; 1997; 30(2):125-8. PubMed ID: 9148335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.